tiprankstipranks
PharmaCyte Biotech (PMCB)
NASDAQ:PMCB

PharmaCyte Biotech (PMCB) Financial Statements

210 Followers

PharmaCyte Biotech Financial Overview

PharmaCyte Biotech's market cap is currently ―. The company's EPS TTM is $-1.196; its P/E ratio is -1.75; PharmaCyte Biotech is scheduled to report earnings on March 16, 2022, and the estimated EPS forecast is $-0.05. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Oct 23Jul 23Apr 23Jan 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.87M$ 2.79M$ -3.18M-$ -1.40M
EBITDA$ -1.87M$ 2.79M$ -3.18M--
Net Income Common Stockholders$ -5.62M$ -2.26M$ -3.50M-$ -764.14K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 61.21M$ 73.43M$ 74.66M$ 68.04M$ 72.64M
Total Assets$ 71.36M$ 78.88M$ 79.88M$ 73.28M$ 77.95M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -61.21M$ -73.43M$ -74.66M$ -68.04M$ -72.64M
Total Liabilities$ 22.47M$ 20.81M$ 37.15M$ 586.58K$ 827.83K
Stockholders Equity$ 31.37M$ 36.77M$ 42.73M$ 72.69M$ 77.12M
Cash Flow-
Free Cash Flow$ -177.10K$ -1.98M$ 342.96K--
Operating Cash Flow$ -177.10K$ -1.98M$ 342.96K--
Investing Cash Flow$ -5.00M----
Financing Cash Flow$ -7.04M$ 748.69K$ 6.28M--
Currency in USD

PharmaCyte Biotech Earnings and Revenue History

PharmaCyte Biotech Debt to Assets

PharmaCyte Biotech Cash Flow

PharmaCyte Biotech Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis